2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …
[HTML][HTML] ISTH guidelines for antithrombotic treatment in COVID‐19
S Schulman, M Sholzberg, AC Spyropoulos… - Journal of Thrombosis …, 2022 - Elsevier
Antithrombotic agents reduce risk of thromboembolism in severely ill patients. Patients with
coronavirus disease 2019 (COVID‐19) may realize additional benefits from heparins …
coronavirus disease 2019 (COVID‐19) may realize additional benefits from heparins …
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
Background Few data are available on the rate and characteristics of thromboembolic
complications in hospitalized patients with COVID-19. Methods We studied consecutive …
complications in hospitalized patients with COVID-19. Methods We studied consecutive …
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
Cancer-associated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology
MB Streiff, B Holmstrom, D Angelini, A Ashrani… - Journal of the National …, 2021 - jnccn.org
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Associated
Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of …
Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of …
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
GD Barnes, A Burnett, A Allen, M Blumenstein… - Journal of thrombosis …, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a viral infection that can, in severe cases,
result in cytokine storm, systemic inflammatory response and coagulopathy that is prognostic …
result in cytokine storm, systemic inflammatory response and coagulopathy that is prognostic …
Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan, China: prevalence, risk factors, and outcome
L Zhang, X Feng, D Zhang, C Jiang, H Mei, J Wang… - Circulation, 2020 - Am Heart Assoc
Background: To investigate deep vein thrombosis (DVT) in hospitalized patients with
coronavirus disease 2019 (COVID-19), we performed a single institutional study to evaluate …
coronavirus disease 2019 (COVID-19), we performed a single institutional study to evaluate …
Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report
Background Emerging evidence shows that severe coronavirus disease 2019 (COVID-19)
can be complicated by a significant coagulopathy, that likely manifests in the form of both …
can be complicated by a significant coagulopathy, that likely manifests in the form of both …
[HTML][HTML] Risk of venous thromboembolism in patients with COVID‐19: a systematic review and meta‐analysis
Background Venous thromboembolism (VTE) is frequently observed in patients with
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …